ZRX1, the first EGFR inhibitor-capecitabine based combi-molecule, requires carboxylesterase-mediated hydrolysis for optimal activity

By Ait-Tihyaty Maria   Rachid Zakaria   Larroque-Lombard Anne-Laure   Jean-Claude Bertrand  

Investigational New Drugs, Vol. 31, Iss. 6, 2013-12 ,pp. : 1409-1423

Springer Publishing Company

Access to resources Recommend Favorite

Panobinostat: The Small Molecule Metalloenzyme Inhibitor with Marvelous Anticancer Activity

By  

Current Topics in Medicinal Chemistry, Vol. 16, Iss. 4, 2016-02 ,pp. : 427-8

Bentham Science Publishers

Access to resources Recommend Favorite

Identifying the Cellular Targets of Bioactive Small Molecules with Activity-Based Probes

By  

Current Medicinal Chemistry, Vol. 17, Iss. 27, 2010-09 ,pp. : 3030-3044

Bentham Science Publishers

Access to resources Recommend Favorite

Sub-lethal Activity of Small Molecules from Natural Sources and their Synthetic Derivatives Against Biofilm Forming Nosocomial Pathogens

By  

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 24, 2013-12 ,pp. : 3184-3204

Bentham Science Publishers

Access to resources Recommend Favorite

Alternative strategies for targeting mouse double minute 2 activity with small molecules: novel patents on the horizon?

By Macchiarulo Antonio   Giacchèè Nicola   Mancini Francesca   Puxeddu Efisio   Moretti Fabiola   Pellicciari Roberto  

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 3, 2011-03 ,pp. : 287-294

Informa Healthcare

Access to resources Recommend Favorite